To subjugate NPY is to improve the quality of life and live longer.
The interactive network of neuropeptide Y (NPY) and cohorts is necessary for integrating the hypothalamic regulation of appetite and energy expenditure with the endocrine and neuroendocrine systems on a daily basis. Genetic and environmental factors that produce an insufficiency of leptin restraint on NPY and cognate receptors deregulate the homeostasis to engender various life-threatening risk factors. Recent studies from our laboratory show that neurotherapy consisting of a single central administration of recombinant adeno-associated virus vector encoding the leptin gene can repress the hypothalamic NPY system for the lifetime of rodents. A major benefit of this stable tonic restraint is deceleration of pathophysiologic sequalae that shorten life span. These include suppression of weight gain, fat accumulation, circulating adipokines, amelioration of major symptoms of metabolic syndrome, improved reproduction and bone health. Thus, sustained repression of NPY signaling in the hypothalamus by leptin transgene expression can improve the quality of life and extend longevity.
Kalra
Satya P
SP
Department of Neuroscience, McKnight Brain Institute, University of Florida, PO Box 100244, Gainesville, FL 32610-0244, USA. skalra@mbi.ufl.edu
Kalra
Pushpa S
PS
D001066:Appetite; D015316:Genetic Therapy; D006801:Humans; D007031:Hypothalamus / Q000502:physiology*; D020738:Leptin / Q000235:genetics; D009478:Neuropeptide Y / Q000037:antagonists & inhibitors / Q000502:physiology*; D011788:Quality of Life
D020738:Leptin; D009478:Neuropeptide Y